Deadly grip of cardiovascular diseases on Filipino families Second part: Breaking hearts and the bank: The cost of heart ...

Managing cholesterol is key to heart health. PSRI Hospital advises early detection, lifestyle changes, and expert care to ...

SLN ("Silence" or "the Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, ...

New research reveals compelling evidence that hormone replacement therapy may offer significant cardiovascular benefits for ...

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited ...

DJ Silence Therapeutics 2024 Loss/Shr 33c “2024 was marked by strong clinical execution and pipeline advancement, highlighting the broad potential of our mRNAi GOLD platform to ...

When Silence Therapeutics unveiled its latest zerlasiran phase 2 data at the American Heart Association (AHA) conference in ...

Amarin (AMRN) highlighted recently published data in the Journal of the American Heart Association showing in a post-hoc analysis of the ...

Coronary artery disease (CAD), or the narrowing of the coronary arteries, is the leading cause of morbidity and mortality ...

Omega-3s are essential fatty acids with a plethora of health benefits. Learn more about foods high in omega-3s so you can add ...

The Company's cash guidance is now extended into 2027 Company to host conference call and webcast today at 8 a.m. EST 1 p.m. GMT Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company") ...

Learn more about whether Exact Sciences Corporation or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.